Chemical and biological weapons. Implications for anaesthesia and intensive care

British Journal of Anaesthesia

Volumn 89, Issue 2, 2002, Pages 306-324

  White, S M ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Complications, warfare; Infection, biological warfare; Intensive care; Toxicity, chemical warfare

Indexed keywords

2 CHLOROBENZYLIDENEMALONONITRILE; ANTIEMETIC AGENT; ATROPINE; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; BRONCHODILATING AGENT; CHEMICAL WARFARE AGENT; CHLORAMPHENICOL; CHLORINE; CIDOFOVIR; CIPROFLOXACIN; CLONIDINE; COBALT EDETATE; DOXYCYCLINE; HYDROGEN CYANIDE; HYDROXOCOBALAMIN; MUSTARD GAS; PENICILLIN G; PHOSGENE; PRALIDOXIME; RIBAVIRIN; RICIN; SARIN; SAXITOXIN; SODIUM NITRITE; SODIUM THIOSULFATE; SOMAN; STREPTOMYCIN; TABUN; UNINDEXED DRUG; CHOLINESTERASE INHIBITOR; IRRITANT AGENT; TOXIN;

BACILLUS ANTHRACIS; BACTERIAL INFECTION; BIOLOGICAL WARFARE; BRUCELLA; BURKHOLDERIA; CONTROLLED STUDY; COXIELLA BURNETII; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG MECHANISM; ESCHERICHIA COLI O157; FRANCISELLA TULARENSIS; HUMAN; HYPERTENSION; HYPOTENSION; INTENSIVE CARE; INTOXICATION; NAUSEA; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SMALLPOX; TERRORISM; VIRUS INFECTION; YERSINIA PESTIS; ANESTHESIA; CHEMICAL WARFARE; EMERGENCY; EMERGENCY HEALTH SERVICE; METHODOLOGY; PATHOGENICITY; VIRUS; WASTE MANAGEMENT;

ANESTHESIA; BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; CHEMICAL WARFARE; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; DECONTAMINATION; EMERGENCIES; HUMANS; INTENSIVE CARE; IRRITANTS; PHOSGENE; TOXINS, BIOLOGICAL; TRIAGE; VIRUSES; YERSINIA PESTIS;

EID: 0035993514     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aef168     Document Type: Review

References (132)

1. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979
2. Multiple actions of anticholinesterase agents on chemosensitive synapses: Molecular basis for prophylaxis and treatment of organophosphate poisoning
3. Clonidine protection from the toxicity of soman, an organophosphate cholinesterase inhibitor, in the mouse
4. Management of respiratory failure in toxic disasters
5. The pre-hospital management of injury following mass toxic release; A comparison of military and civil approaches
6. Single fibre electromyographic changes in man after organophosphate exposure
7. Clinical and laboratory findings in Iranian fighters with chemical gas poisoning
8. Neurotoxins in the study of neural regulation of membrane proteins in skeletal muscle
9. Cyanide poisoning
10. Paralytic ileus as a complication of atropine therapy following severe organophosphate poisoning
11. Report on five cases of tularaemic pneumonia in a tularaemia outbreak in Spain
12. Reversal of saxitoxin-induced cardiorespiratory failure by a burro-raised alpha-STX antibody and oxygen therapy
13. Noninvasive measurement of microvascular leakage in patients with dengue haemorrhagic fever
14. Vaccines for smallpox
15. Agents of chemical warfare: Sulfur mustard
16. Death due to bioterrorism-related inhalational anthrax. Report of 2 patients
17. Brucellosis: A worldwide zoonosis
18. Chemical warfare agents: Emergency medical and emergency public health issues
19. Yersinia species, including plague
20. Bioterrorism alleging use of anthrax and interim guidelines for management: United States, 1998
21. Laboratory-acquired human glanders-Maryland
22. Anti-idiotype-based vaccines against biological toxins
23. Haemorrhagic fever virus-induced changes in hemostasis and vascular biology
24. Biological Warfare: A historical perspective
25. Effects of phenytoin, ketamine, and atropine methyl nitrate in preventing neuromuscular toxicity of acetylcholinesterase inhibitors soman and disopropylphosphorofluoridate
26. Ebola haemorrhagic fever-a review
27. A Survey of Chemical and Biological Warfare
28. Decontamination and management of hazardous materials exposure victims in the emergency department
29. Arenaviral haemorrhagic fevers
30. Eye lesions induced by mustard gas
31. Plague immunisation
32. Why should we be concerned about biological warfare?
33. Review of oximes available for treatment of nerve agent poisoning
34. Anthrax
35. Enzymes as pretreatment drugs for organophosphate toxicity
36. The chemical war: Iran revisited-1986
37. Vomiting agents
38. Chemical and Bacteriological (Biological) Weapons and the Effects of Their Possible Use
39. America's Achilles' Heel. Nuclear, Biological and Chemical Terrorism and Covert Attack
40. Haemolytic uraemic syndrome and E. coli O157
41. The genetic toxicology of nitrogen and sulfur mustard
42. International Biological Warfare Threat in CONUS
43. Clinical recognition and management of patients exposed to biological warfare agents
44. Emerging infectious diseases and risk to the traveller
45. Mechanism of phosgene-induced lung toxicity: Role of arachidonate mediators
46. An integrated response to chemical incidents-the UK perspective
47. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate
48. Smallpox as a biological weapon: Medical and public health management. Working Group on Civilian Biodefense
49. Chemical warfare injuries
50. Chemical warfare. Nerve agent poisoning
51. In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals
52. The Cult at the End of the World
53. Organophosphorus poisoning and anaesthesia
54. Ocular signs and symptoms caused by exposure to sarin gas
55. Smallpox vaccine
56. The economic impact of a bioterrorist attack: Are prevention and past attack programs justifiable?
57. Interactions between nerve agent pretreatment and drugs commonly used in combat anaesthesia
58. Biological and chemical terrorism: Strategic plan for preparedness and response
59. Viral hemorrhagic fevers
60. Prophylactic and therapeutic efficacy of an avian antitoxin in ricin intoxication
61. Sequelae of Venezuelan equine encephalitis in humans: A four year follow-up
62. Anthrax toxin edema factor: A bacterial adenylate cyclase that increases cyclic AMP concentrations in eukaryotic cells
63. Ricin: Structure, mode of action, and some current applications
64. Treatment of acute organophosphate poisoning
65. The pathogenesis of organophosphate polyneuropathy
66. Role of edrophonium in prevention of the re-inhibition of acetylcholinesterase by phosphorylated oxime
67. Weapons of mass destruction events with contaminated casualties: Effective planning for health care facilities
68. Pyridostigmine
69. Organophosphate poisoning
70. Treatment and prophylaxis of organophosphate nerve agent poisoning
71. Q fever
72. Immunologic interference from sequential administration of live attenuated alphavirus vaccines
73. Anticonvulsant treatment of nerve agent seizures: Anticholinergics versus diazepam in soman-intoxicated guinea pigs
74. Cutaneous manifestations of biological warfare and related threat agents
75. Plague
76. Italian epidemic of waterborne tularaemia
77. Emergency medical services systems and HAZMAT major incidents
78. Clinical analogies for the management of toxic trauma
79. BMA. Biotechnology Weapons and Humanity
80. Relationship between pupil size and acetylcholinesterase activity in patients exposed to sarin vapor
81. Secondary exposure of medical staff to sarin vapor in the emergency room
82. Lassa fever: Review of virology, immunopathogenesis, and algorithms for control and therapy
83. Effects of anthrax toxin components on human neutrophils
84. The Conspiracy of Pontiac and the Indian War After the Conquest of Canada
85. Effects of intrasphincteric botulinum toxin on the lower esophageal sphincter in piglets
86. Neuromuscular blockade by neostigmine in anaesthetized man
87. Yersinia pestis-etiologic agent of plague
88. Pathogenesis of viral haemorrhagic fevers: Rift Valley fever and Lassa fever contrasted
89. Anthrax as a potential biological warfare agent
90. Continuous infusion of high doses of atropine in the management of organophosphorus compound poisoning
91. Central respiratory effects versus neuromuscular actions of nerve agents
92. Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995
93. Chemical warfare in the Iraq-Iran war
94. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders
95. Shellfish and fish poisoning related to the toxic dinoflagellates
96. Q fever in an urban area
97. The tularaemia vaccine
98. Protective effects of N-acetylcysteine treatment after phosgene exposure in rabbits
99. Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome
100. Inhalational anthrax: Epidemiology, diagnosis and management
101. Medical preparedness for a terrorist incident involving chemical or biological agents during the 1996 Atlanta Olympic Games
102. Chemical agent terrorism
103. Neurophysiological monitoring of pharmacological manipulation in acute organophosphate (OP) poisoning. The effects of pralidoxime, magnesium sulphate and pancuronium
104. Terrorism in America. An evolving threat
105. The neurologic effects of noxious marine creatures
106. Chemical Warfare
107. Development of a preventative vaccine for Ebola virus infection in primates
108. The enigmatic haemorrhagic fevers
109. Brief bilateral vocal cord paralysis after insecticide poisoning. A new variant of toxicity syndrome
110. National health and medical services response to incidents of chemical and biological terrorism
111. Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons and on Their Destruction
112. Toxic inhalation injury
113. Latin American hemorrhagic fever
114. Diagnosis and treatment of organophosphate and carbamate intoxication
115. Organic neurotoxins in seafoods
116. Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America
117. Anaesthesia and critical care considerations in nerve agent warfare trauma casualties
118. Primary plague pneumonia contracted from a domestic cat at South Lake Tahoe, Calif
119. Ebola haemorrhagic fever in Zaire
120. Ebola haemorrhagic fever in Sudan, 1976
121. Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning
122. Effect of human plasma on the reactivation of sarin-inhibited human erythrocyte acetylcholinesterase
123. Riot control agents